The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide
Bibliography: Domestic Policy Issues
Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms
Framework for action for integrated care boards (ICBs) and primary care (NHS England)
Synthetic opioids will be banned as government acts to stop drug deaths
Eleven more lethal substances to be made Class A drugs, following a recommendation by the Advisory Council on the Misuse of Drugs (Home Office)
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions (Australian Government)
Rapid Action Drug Alerts and Response (RADAR) quarterly report
The Drugs Team at Public Health Scotland (PHS) has compiled this report of drug-related indicators in order to inform action to prevent drug harms and deaths
Drug Deaths Taskforce response: cross government approach
Cross government response to the Drug Deaths Taskforce report, Changing Lives. It contains a cross government action plan, response to Taskforce recommendations and a stigma action plan (Scottish Government)
High Intensity Drug Trafficking Areas Program 2022 Report to Congress
This document presents a national overview of the HIDTA Program, including an evaluation of each HIDTA, and addresses the following three Congressional reporting requirements in one cohesive and coordinated report (White House)
Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use
The Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use in which it makes a series of recommendations on the issue (Houses of the Oireachtas, Ireland)
Cannabis in Australia
More than a third of Australians aged over 14 have used cannabis at least once – 37%, or 7.6 million people. Around 2.4 million Australians used cannabis in 2019, as did 200 million people worldwide (Penington Institute)
National naloxone programme Scotland – Quarterly monitoring bulletin
Quarterly Monitoring Bulletin April to June (Q1) 2022/23 (Public Health Scotland)
Experiences of Harm Reduction Service Providers During Dual Public Health Emergencies in Canada
This study initially set out to gain a better understanding of the effect of the overdose emergency from harm reduction service providers’ perspective. However, with the onset of COVID-19, CCSA expanded the study to identify the additional effects of dual public health emergencies (CCSA)
National Mission on Drugs: annual report 2021 to 2022
Sets out the progress made between January 2021 and 31 March 2022 by national government, local government and third sector partners towards reducing drug deaths and improving the lives of those impacted by drugs in Scotland Download (Scottish Government)
Injecting equipment provision in Scotland
This release by Public Health Scotland (PHS) presents information on injecting equipment provision (IEP). This includes the number of outlets, attendances and the types of injecting equipment distributed to people who use illicit drugs (including Novel Psychoactive Substances and Image and Performance Enhancing Drugs) in Scotland in 2021/22
Interim monitoring report on statutory funded residential rehabilitation placements
Placements approved by Alcohol and Drug Partnerships between 01 April 2021 to 30 June 2022 (Public Health Scotland)
Drug and Alcohol Treatment and Recovery Workforce Programme
This programme aims to transform the lives of those affected by drug and alcohol misuse by improving the quality and capacity of the drug and alcohol treatment and recovery workforce (NHS)
Actions Taken by the Biden-Harris Administration to Address Addiction and the Overdose Epidemic
At a time when overdose deaths, driven primarily by illicitly manufactured synthetic drugs, have reached a record high, the Biden-Harris Administration has significantly expanded access to evidence-based prevention, treatment, harm reduction, and recovery support services, as well as taken action to reduce the supply of illicit drugs like fentanyl
Irish Syringe Analysis Pilot Project
The identication of current injecting trends in the Dublin and Midland Region through the application of syringe analysis methodology (MQI)
Commissioning quality standard: alcohol and drug services
Guidance for local authorities to support them in commissioning effective alcohol and drug treatment and recovery services in their areas (Office for Health Improvement and Disparities, UK)
List of most commonly encountered drugs currently controlled under the misuse of drugs legislation
The following is a list of the most commonly encountered drugs currently controlled under the misuse of drugs legislation showing their respective classifications under both the Misuse of Drugs Act 1971 (MDA) and the Misuse of Drugs Regulations 2001 (MDR) Home Office, UK
Swift, Certain, Tough – New consequences for drug possession
Presented to Parliament by the Secretary of State for the Home Department
- 1
- 2
- 3
- …
- 22
- Next Page »
